BANK OF MAHARASHTRA Surges by 9%; BSE BANKEX Index Up 0.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  •
  • MyStocks
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BANK OF MAHARASHTRA Surges by 9%; BSE BANKEX Index Up 0.2%
Wed, 20 Nov 09:20 AM

BANK OF MAHARASHTRA share price has zoomed 9% and is presently trading at Rs 13.

Meanwhile, the BSE BANKEX Index is at 35,482 (up 0.2%).

Among the top Gainers in the BSE BANKEX Index today is BANK OF MAHARASHTRA (up 9.0%).

HDFC BANK and AXIS BANK (down 0.1%) are among the top losers today.

Over the last one year, BANK OF MAHARASHTRA has moved down from Rs 15 to Rs 13, registering a loss of Rs 2 (down 15.0%).

On the other hand, the BSE BANKEX has moved up from 29,603 to 35,482, registering a gain of 5,879 points (up 19.6%) during the last 12 months.

The top gainers among the BSE BANKEX Index stocks during this same period were KOTAK MAHINDRA BANK (up 38.2%), ICICI BANK (up 37.1%) and CITY UNION BANK (up 29.5%).

10 Charts, 1 Growth Story: Join us for an Exclusive Webinar LIVE on April 23rd @6pm

What About the Benchmark Indices?

The BSE Sensex is at 40,736 (up 0.4%).

The top gainers among the BSE Sensex stocks today are RELIANCE IND. (up 2.9%), BHARTI AIRTEL (up 1.8%) and COAL INDIA (up 1.7%). Other gainers include INDUSIND BANK (up 1.4%) and ASIAN PAINTS (up 1.1%). The most traded stocks in the BSE Sensex are BAJAJ AUTO and MARUTI SUZUKI.

In the meantime, NSE Nifty is at 12,005 (up 0.5%). RELIANCE IND. (up 3.0%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,775 to 40,736, registering a gain of 4,961 points (up 13.5%).

BANK OF MAHARASHTRA Financial Update...

BANK OF MAHARASHTRA net profit declined 103.0% YoY to Rs 1 billion for the quarter ended September 2019, compared to a loss of Rs 38 billion a year ago. Operating income rose 9.6% to Rs 29.0 billion during the period as against Rs 26.5 billion in July-September 2018.

For the year ended March 2019, BANK OF MAHARASHTRA reported 328.3% increase in net profit to Rs 47.6 billion compared to net profit of Rs 11.1 billion during FY18.

Revenue of the company grew 2.2% to Rs 108 billion during FY19.

The current Price to earnings ratio of BANK OF MAHARASHTRA, based on rolling 12 month earnings, stands at down 1.0x.

Archives

RSS RSS



What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "BANK OF MAHARASHTRA Surges by 9%; BSE BANKEX Index Up 0.2%". Click here!

  

Stock Market Updates

Sensex Trades On a Volatile Note, Dow Futures Up by 68 Points (Today's Market)

Apr 20, 2021 12:30 pm

Share markets in India are presently trading on a volatile note. The BSE Sensex is trading up by 11 points, flat, at 47,960 levels.

WOCKHARDT Share Price Up by 13%; BSE HEALTHCARE Index Up 1.4% (Today's Market)

Apr 20, 2021 12:42 PM

WOCKHARDT share price is trading up by 13% and its current market price is Rs 527. The BSE HEALTHCARE is up by 1.4%. The top gainers in the BSE HEALTHCARE Index are WOCKHARDT (up 12.6%) and ASTRAZENECA PHARMA (up 5.7%). The top losers are GSK PHARMA and ALKEM LABORATORIES (down 0.1%).

Sensex Opens 440 Points Higher; Nestle India and ACC Among Top Stocks in Focus (Today's Market)

Apr 20, 2021 09:30 am

Indian share markets open in green. The BSE Sensex opened up by 440 points, while the Nifty is trading higher by 133 points.

SOBHA Share Price Up by 8%; BSE REALTY Index Up 1.3% (Today's Market)

Apr 20, 2021 09:50 AM

SOBHA share price is trading up by 8% and its current market price is Rs 536. The BSE REALTY is up by 1.3%. The top gainers in the BSE REALTY Index is SOBHA (up 7.6%). The top losers are PHOENIX MILL (down 0.1%) and OMAXE (down 4.0%).

CIPLA at All Time High; BSE HEALTHCARE Index Up 1.1% (Today's Market)

Apr 20, 2021 09:44 AM

CIPLA share price has hit an all time high at Rs 966 (up 0.6%). The BSE HEALTHCARE Index is up by 1.1%. Among the top gainers in the BSE HEALTHCARE Index today are CIPLA (up 0.6%) and ABBOTT INDIA (up 1.1%). The top losers include PROCTER & GAMBLE HEALTH (down 0.3%) and BIOCON (down 0.3%).

GLENMARK PHARMA at 52 Week High; BSE 500 Index Up 1.0% (Today's Market)

Apr 20, 2021 09:26 AM

GLENMARK PHARMA share price has hit a 52-week high. It is presently trading at Rs 589. BSE 500 Index is up by 1.1% at 19,461. Within the BSE 500, GLENMARK PHARMA (up 0.1%) and ICICI PRUDENTIAL LIFE INSURANCE (up 6.7%) are among the top gainers, while top losers are GE POWER INDIA and OMAXE.

View More Indian Share Market News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Warning About Bubbles(Fast Profits Daily)

Apr 16, 2021

Those who don't learn from financial history are doomed to lose their money.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

S&P BSE SENSEX


Apr 20, 2021 03:02 PM

FEATURED VIDEOS

Stability, Quality or Green Stocks for 2021?

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

More Featured Videos

MARKET STATS


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
FOLLOW
  • Follow on YouTube
  • Follow on LinkedIn Follow @Equitymaster Follow on RSS Follow on Telegram

APP
  • Get Equitymaster Android App on Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.